u/Embarrassed-Sea-6078

I have always been fascinated by the connections between music and emotions. Also I know different composers also have drawn upon their own mental state to create pieces that are phenomenal.

I was hoping for an interesting exercise and would love to hear people’s thoughts on which classical music might best exemplify/represent all the following psychiatric illnesses:

Depression
Psychosis
Bipolar
Anxiety
PTSD

I have always been fascinated by the connections between music and emotions. Also I know different composers also have drawn upon their own mental state to create pieces that are phenomenal.

I was hoping for an interesting exercise and would love to hear people’s thoughts on which classical music might best exemplify/represent all the following psychiatric illnesses:

Depression
Psychosis
Bipolar
Anxiety
PTSD
ADHD

I am looking to add a bit more into my healthcare portfolio, does anyone have a good healthcare stocks currently that is worth purchasing? Thanks!

Currently is ALB at a good investment point? It certainly is in a favored field with energy and batteries especially in this current environment. It had a previous PE of ~ -33, but the forward PE is probably more around ~+23 which shows that there should be a turnaround in the outlooks. Last earnings report there was a significant net loss of $400 million, but it sounds like there’s a significant improvement in revenue for this year already. How do people feel about ALB or is the optimism too unrealistic? Is it a good time to pick up the stock currently given the unfavorable views from last earnings report and the potential of this upcoming earnings report? Definitely appreciate everyone’s perspectives on this.

LLY really has taken a beating recently. It went from a high of 1134 to now around 882. Part of the issue is the impression of it not doing as well in its weight loss drug especially against multiple upcomers like NVO. But the other main issue is the huge price target drop from $1070 to $850 by HSBC.

LLY did beat its previous earnings target by about 8%, the current expectation is that it will beat the upcoming earnings again, but question is how much and how significantly does it have to beat it for wall street to look at it positively.

But LLY should always have a place as a long term investment right? It would always have a good growth within the pharmaceutical industry?

When would the price become reasonable enough to enter?